Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina

Espinola N, Secco A, Balan D, Kanevsky D, Calvi G, Morisset P, et al. Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. Rev Peru Med Exp Salud Publica. 2024;41(2):129-39.